These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10599884)

  • 1. Alpha-2 domain polymorphism and HLA class I peptide loading.
    Prilliman KR; Crawford D; Hickman HD; Jackson KW; Wang J; Hildebrand WH
    Tissue Antigens; 1999 Nov; 54(5):450-60. PubMed ID: 10599884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.
    Fleischhauer K; Avila D; Vilbois F; Traversari C; Bordignon C; Wallny HJ
    Tissue Antigens; 1994 Nov; 44(5):311-7. PubMed ID: 7878657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction.
    Hildebrand WH; Turnquist HR; Prilliman KR; Hickman HD; Schenk EL; McIlhaney MM; Solheim JC
    Hum Immunol; 2002 Apr; 63(4):248-55. PubMed ID: 12039406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B15 peptide ligands are preferentially anchored at their C termini.
    Prilliman KR; Jackson KW; Lindsey M; Wang J; Crawford D; Hildebrand WH
    J Immunol; 1999 Jun; 162(12):7277-84. PubMed ID: 10358176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
    Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
    J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The South Amerindian allotype HLA-B*3909 has the largest known similarity in peptide specificity and common natural ligands with HLA-B27.
    Yagüe J; Ramos M; Vázquez J; Marina A; Albar JP; López de Castro JA
    Tissue Antigens; 1999 Mar; 53(3):227-36. PubMed ID: 10203015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexity among constituents of the HLA-B*1501 peptide motif.
    Prilliman KR; Lindsey M; Jackson KW; Cole J; Bonner R; Hildebrand WH
    Immunogenetics; 1998 Jul; 48(2):89-97. PubMed ID: 9634472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules.
    Choo SY; Fan LA; Hansen JA
    Immunogenetics; 1993; 37(2):108-13. PubMed ID: 8423049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A post-translational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligand.
    Yagüe J; Vázquez J; López de Castro JA
    Protein Sci; 2000 Nov; 9(11):2210-7. PubMed ID: 11152131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus macaque MHC class I molecules present HLA-B-like peptides.
    Hickman-Miller HD; Bardet W; Gilb A; Luis AD; Jackson KW; Watkins DI; Hildebrand WH
    J Immunol; 2005 Jul; 175(1):367-75. PubMed ID: 15972670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells.
    Hickman HD; Batson CL; Prilliman KR; Crawford DL; Jackson KL; Hildebrand WH
    Hum Immunol; 2000 Dec; 61(12):1339-46. PubMed ID: 11163091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
    Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
    J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.
    Herman J; Jongeneel V; Kuznetsov D; Coulie PG
    Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
    Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
    Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?
    van Deutekom HW; Keşmir C
    Immunogenetics; 2015 Aug; 67(8):425-36. PubMed ID: 26040913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell recognition of MHC class I. NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells.
    Kurago ZB; Smith KD; Lutz CT
    J Immunol; 1995 Mar; 154(6):2631-41. PubMed ID: 7876538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion.
    Zernich D; Purcell AW; Macdonald WA; Kjer-Nielsen L; Ely LK; Laham N; Crockford T; Mifsud NA; Bharadwaj M; Chang L; Tait BD; Holdsworth R; Brooks AG; Bottomley SP; Beddoe T; Peh CA; Rossjohn J; McCluskey J
    J Exp Med; 2004 Jul; 200(1):13-24. PubMed ID: 15226359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide specificity of the Amerindian B*3905 allotype: molecular insight into selection mechanisms driving HLA class I evolution in indigenous populations of the Americas.
    Yagüe J; Ramos M; Ogueta S; Vázquez J; López de Castro JA
    Tissue Antigens; 2000 Nov; 56(5):385-91. PubMed ID: 11144286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B15: a widespread and diverse family of HLA-B alleles.
    Hildebrand WH; Domena JD; Shen SY; Lau M; Terasaki PI; Bunce M; Marsh SG; Guttridge MG; Bias WB; Parham P
    Tissue Antigens; 1994 Apr; 43(4):209-18. PubMed ID: 7521976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of peptides presented by an HLA class I low expression allele.
    Hinrichs J; Föll D; Bade-Döding C; Huyton T; Blasczyk R; Eiz-Vesper B
    Haematologica; 2010 Aug; 95(8):1373-80. PubMed ID: 20220067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.